Related Experiment Video
Updated: Aug 14, 2026

Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
A prion disease--possible Gerstmann-Straussler-Scheinker disease: a case report
Ayse Aralasmak1, Barbara J Crain, Wen-Quan Zou
1Russell H. Morgan Department of Radiology and Radiological Science, Division of Neuroradiology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA. aysearalasmak@hotmail.com
Gerstmann-Straussler-Scheinker disease, a rare prion disorder, was diagnosed in a patient with progressive cognitive and motor decline. Brain biopsy revealed the characteristic protease-resistant prion protein fragment, confirming the diagnosis.
Area of Science:
- Neuroscience
- Neuropathology
- Prion Diseases
Background:
- Gerstmann-Straussler-Scheinker disease (GSS) is a rare, inherited prionopathy characterized by progressive neurological decline.
- Clinical presentation can vary, often including ataxia, dementia, and motor deficits, typically without myoclonus.
- Diagnostic challenges exist due to overlapping symptoms with other neurodegenerative disorders.
Observation:
- A 50-year-old patient presented with a 6-month history of progressive cognitive and motor disability.
- Neurological examination revealed no myoclonic jerks, and electroencephalography showed no periodic sharp waves.
- Brain imaging demonstrated T2-weighted hyperintensities in the basal ganglia and posterior internal capsules, without restricted diffusion or volume loss.
Findings:
- A brain biopsy was performed for definitive diagnosis.
- Western blot analysis identified a protease-resistant prion protein fragment (PrP7-8).
- The presence of PrP7-8 is the molecular hallmark confirming Gerstmann-Straussler-Scheinker disease.
Implications:
- This case highlights the importance of considering GSS in patients with progressive neurological deficits, even without typical EEG findings.
- Molecular confirmation via prion protein analysis is crucial for accurate diagnosis of GSS.
- Understanding the molecular pathology of GSS aids in differentiating it from other prion and neurodegenerative diseases.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease l: Introduction
Parkinson Disease l: Introduction
Subviral Agents
Huntington Disease l: Introduction

